Psychosis and Low Cyanocobalamin in a Patient Abusing Nitrous Oxide and Cannabis

Psychosomatics

Volumn 55, Issue 6, 2014, Pages 715-719

  Garakani, Amir ^a,b,c   Welch, Alison K ^a   Jaffe, Robert J ^a   Protin, Caroline A ^d   McDowell, David M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SILVER HILL HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABINOID; CANNABIS; CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; MULTIVITAMIN; NICOTINE GUM; NITROUS OXIDE; RISPERIDONE;

ADULT; ARTICLE; BEHAVIOR CHANGE; CANNABIS ADDICTION; CANNABIS USE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG URINE LEVEL; EVENING DOSAGE; FATIGUE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MALE; OUTPATIENT; PARANOIA; PARAPSYCHOLOGY; PSYCHIATRIC DEPARTMENT; PSYCHIATRIST; PSYCHOSIS; SMOKING; XEROSTOMIA; YOUNG ADULT; CHEMICALLY INDUCED; COMPLICATION; CYANOCOBALAMIN DEFICIENCY; DRUG DEPENDENCE; PSYCHOSES, SUBSTANCE-INDUCED;

HUMANS; MALE; MARIJUANA ABUSE; NITROUS OXIDE; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE-RELATED DISORDERS; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 84926408271     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.11.001     Document Type: Article

References (27)

1. Wu L.T., Pilowsky D.J., Schlenger W.E. Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry 2004, 43(10):1206-1214.
2. Garland E.L., Howard M.O., Perron B.E. Nitrous oxide inhalation among adolescents: prevalence, correlates, and co-occurrence with volatile solvent inhalation. J Psychoactive Drugs 2009, 41(4):337-347.
3. Krajewski W., Kucharska M., Pilacik B., et al. Impaired vitamin B12 metabolic status in healthcare workers occupationally exposed to nitrous oxide. Br J Anaesth 2007, 99(6):812-818.
4. Meyers L.E., Judge B.S. Myeloneuropathy in a dentist. Clin Toxicol 2008, 46(10):1095-1096.
5. Hathout L., El-Saden S. Nitrous oxide-induced B-12 deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B12. J Neurol Sci 2011, 301(1-2):1-8.
6. Diamond A.L., Diamond R., Freedman S.M., Thomas F.P. "Whippets"-induced cobalamin deficiency manifesting as cervical myelopathy. J Neuroimaging 2004, 14(3):277-280.
7. Waclawik A.J., Luzzio C.C., Juhasz-Pocsine K., Hamilton V. Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels. WMJ 2003, 102(4):43-45.
8. Shulman R.M., Geraghty T.J., Tadros M. A case of unusual substance abuse causing myeloneuropathy. Spinal Cord 2007, 45(4):314-317.
9. Lin R.J., Chen H.F., Chang Y.C., Su J.J. Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurol Taiwan 2011, 20(2):129-137.
10. Winek C.L., Wahba W.W., Rozin L. Accidental death by nitrous oxide inhalation. Forensic Sci Int 1995, 73(2):139-141.
11. Potocka-Banas B., Majdanik S., Dutkiewicz G., Borowiak K., Janus T. Death caused by addictive inhalation of nitrous oxide. Hum Exp Toxicol 2011, 30(11):1875-1877.
12. Brodsky L., Zuniga J. Nitrous oxide: a psychotogenic agent. Compr Psychiatry 1975, 16(2):185-188.
13. Sethi N.K., Mullin P., Torgovnick J., Capasso G. Nitrous oxide "whippit" abuse presenting with cobalamin responsive psychosis. J Med Toxicol 2006, 2(2):71-74.
14. Celine C., Gunter H., Kurt A. Laughing gas abuse is no joke. An overview of the implications for psychiatric practice. Clin Neurol Neurosurg 2013, 115(7):859-862.
15. Evatt ML, Mersereau PW, Bobo JK, Kimmons J, Williams J: Why vitamin B12 deficiency should be on your radar screen. Centers for Disease Control and Prevention. Available from: . Accessed 10/24/2013. http://www.cdc.gov/ncbddd/b12/index.html.
16. Emmanouil D.E., Quock R.M. Advances in understanding the actions of nitrous oxide. Anesth Prog 2007, 54(1):9-18.
17. Masalha R., Chudakov B., Muhamad M., Rudoy I., Volkov I., Wirguin I. Cobalamin-responsive psychosis as the sole manifestation of vitamin B12 deficiency. Isr Med Assoc J 2001, 3(9):701-703.
18. Bar-Shai M., Gott D., Marmor S. Acute psychotic depression as a sole manifestation of vitamin B12 deficiency. Psychosomatics 2011, 52(4):384-386.
19. Payinda G., Hansen T. Vitamin B(12) deficiency manifested as psychosis without anemia. Am J Psychiatry 2000, 157(4):660-661.
20. Lindenbaum J., Healton E.B., Savage D.G., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988, 318(26):1720-1728.
21. Hutto B.R. Folate and cobalamin in psychiatric illness. Compr Psychiatry 1997, 38(6):305-314.
22. Snow C.F. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med 1999, 159(12):1289-1298.
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.
24. Larson M.K., Walker E.F., Compton M.T. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother 2010, 10(8):1347-1359.
25. Paparelli A., Di Forti M., Morrison P.D., Murray R.M. Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Front Behav Neurosci 2011, 5:1.
26. Henquet C., Di Forti M., Morrison P., Kuepper R., Murray R.M. Gene-environment interplay between cannabis and psychosis. Schizophrenia Bull 2008, 34(6):1111-1121.
27. Minozzi S., Davoli M., Bargagli A.M., Amato L., Vecchi S., Perucci C.A. An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev 2010, 29(3):304-317.